The Ontario Hereditary Cancer Research Network's (OHCRN) participant portal is now open and Ontarians at risk of hereditary cancers are invited to register.

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD(TM) CorEvitas(TM) Myasthenia Gravis (MG) Registry. This ...

The RARE Summit 2025 proved its value to the rare disease community with a packed day of events, talks and opportunities to make connections, exchange ideas and openly debate possibilities.

Nobody really knows how to speak to the future in a way that it will hear.

To stay ahead in an increasingly complex geopolitical landscape, the British defence sector must be able to gather ...

A new project is looking how chats between hair stylists and clients can raise awareness about positive actions to take around climate change ...

Australia has one of the lowest rates of cerebral palsy in the world, which Nadia Badawi wants to replicate in other ...

As Director of IIT Kanpur, Manindra Agrawal heads one of the most prestigious research and innovation hubs in the country.

The Ontario Hereditary Cancer Research Network (OHCRN) is a first-of-its-kind provincial registry that will collect and leverage critical data on all types of hereditary cancers to drive life-changing ...

Homeownership is a bucket list item for many, but soaring property taxes can quickly turn that fantasy into a financial ...

The research will support the implementation of precision medicine efforts for the population. Read more at straitstimes.com. Read more at straitstimes.com.